*CorMedix, Heron: Transaction Expected Immediately Accretive to CorMedix Earnings, Free Cash Flow, as Well as Estimated to Generate $45M-$60 M in Near-Term Total Operating Cost Synergies >CRMD

Dow Jones · 2d ago

Please log in to view news